Aperiomics CEO Dr. Crystal Icenhour, Interviews on the Talk Show Primary Care Cures

 

About: Primary Care Cures the Talk Show

Primary Care Cures allows viewers to meet various makers of change, thought leaders, daring disrupters’ and quiet innovators. They particularly spotlight Physicians and entrepreneurs revolutionizing many industries. In this episode, host Ron Barshop talks to Crystal Icenhour about how she and her company plan to revolutionize healthcare by identifying the causes of reoccurring illnesses.

Here is a LINK to episode #11- Crystal Icenhour.

 

Overview

When it comes to reoccurring infections, Aperiomics has helped people find answers to the root cause of their illness that seemed impossible to find. Most physicians only have access to a diagnostic test that can screen for a limited number of pathogens leading to chronic or reoccurring infection totaling hundreds of dollars per species tested for. For each sample collected, Aperiomics takes a sampling of the total genetic information, up to one terabyte of data. The medical testing company has developed one of the largest databases of every microorganism know to modern science, which gives us the ability to identify every known bacteria, virus, fungus, and parasite infecting a patient.

 

About Ron Barshop

Ron Barshop began his career at Phone Power, an inbound telemarketing tax service. In just two years, as Executive Vice President, Ron singlehandedly took the business from five to 50 employees and recruited major clients like Walmart, Hilton Hotels, and McDonalds — all before the age of 25.

He took his talent for business growth to the Financial Process Group, which went from 3 to 50 employees and became a Top 2% performer under Barshop’s leadership. In his next role as President of a multi-city radio network, he raised several million dollars in capital and increased station revenues by 120% in just 18 months.

Barshop’s move into primary care began when he co-founded and presided over AMPD, an ancillary income provider for PCP offices, and Smart Allergy Labs, which served 50 clinics over three states in its first nine months alone.

Today, Barshop is CEO of Beacon Clinics, a leading ancillary income provider for primary care providers. Beacon is top-in-class for improving allergy outcomes, increasing patient volume, and developing industry-leading safety protocols.

 

About Dr. Icenhour, CEO of Aperiomics

Crystal R. Icenhour received her PhD in Pathobiology and Molecular Medicine from the University of Cincinnati Medical School of Graduate Studies in 2002.  She conducted postdoctoral research in the Thoracic Diseases Research Unit at the Mayo Clinic College of Medicine from 2002-2005 and in the Department of Infectious Diseases at Duke University Medical Center from 2005-2006.

Dr. Icenhour has been involved in local and national postdoctoral associations including the Mayo Research Fellows Association Executive Committee (President), the Duke University Postdoctoral Association (chair of the membership committee), and the National Postdoctoral Association (2008 Chair).  Dr. Icenhour has participated in numerous events aimed at supporting and mentoring women in STEM.

She has also been recognized by Kauffman Foundation and Center for Innovative Technology as an outstanding entrepreneur. In 2014 Dr. Icenhour was recruited as CEO of Aperiomics in Ashburn, Virginia.  Aperiomics’ focus is to harness the power of next-generation sequencing to improve world health.